<DOC>
	<DOC>NCT01039506</DOC>
	<brief_summary>The purpose of this study is to examine the correlation between UGT1A1 genotypes and the efficacy of CPT-11 based regimens (FOLFIRI, CPT-11+S-1, CPT-11) for patients with metastatic colorectal cancer.</brief_summary>
	<brief_title>An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in mCRC</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Metastatic colorectal cancer (adenocarcinoma) UGT1A1 genotyped patients Patients to receiving FOLFIRI, CPT11+S1 and CPT11 alone therapy (with or without molecular targeted agents) Contraindication of CPT11 ECOG PS 34 Patients to receiving CPT11 as adjuvant chemotherapy History of pelvic irradiation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>UGT1A1, irinotecan</keyword>
</DOC>